Shanghai Titan Scientific Co., Ltd. Stock

Equities

688133

CNE100005XG3

Specialty Chemicals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
29.92 CNY -2.03% Intraday chart for Shanghai Titan Scientific Co., Ltd. +3.85% -35.45%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2023 2.77B 384M Sales 2024 * 3.19B 442M Capitalization 3.53B 489M
Net income 2023 72M 9.97M Net income 2024 * 100M 13.84M EV / Sales 2023 1.97 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 1.11 x
P/E ratio 2023
74.8 x
P/E ratio 2024 *
35.1 x
Employees 1,381
Yield 2023
0.22%
Yield 2024 *
0.37%
Free-Float 63.28%
More Fundamentals * Assessed data
Dynamic Chart
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shanghai Titan Scientific Co., Ltd. agreed to acquire 30% stake in Shanghai Magal Scientific Instrument Co., Ltd. from Wu Gang and Ling Hui. CI
Shanghai Titan Scientific Co., Ltd. agreed to acquire 26.6667% stake in RADOBIO Scientific Co., Ltd. CI
Shanghai Magal Scientific Instrument Co., Ltd. announced that it expects to receive CNY 12 million in funding from Shanghai Titan Scientific Co., Ltd., Shanghai Titan Heyuan I Venture Capital Investment Partnership Enterprise (Limited Partnership) CI
RADOBIO Scientific Co., Ltd. announced that it expects to receive CNY 16 million in funding from Shanghai Titan Scientific Co., Ltd., Shanghai Titan Heyuan I Venture Capital Investment Partnership Enterprise (Limited Partnership) CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai Titan Scientific Co., Ltd.(XSSC:688133) added to S&P Global BMI Index CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Milestone® Biotechnologies announced that it has received CNY 100 million in funding from Haichuang Tiancheng Equity Investment Fund Management Co., Ltd., Jiangsu Addor Equity Investment Fund Management Co., Ltd., GL Ventures, Shanghai Titan Scientific Co., Ltd., Jiaxing Tongyu Private Equity Fund Management Co., Ltd. CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news
1 day-2.03%
1 week+3.85%
Current month+3.85%
1 month-3.27%
3 months+2.50%
6 months-44.60%
Current year-35.45%
More quotes
1 week
29.01
Extreme 29.01
31.35
1 month
24.51
Extreme 24.51
31.40
Current year
24.51
Extreme 24.51
47.02
1 year
24.51
Extreme 24.51
86.65
3 years
24.51
Extreme 24.51
239.27
5 years
24.51
Extreme 24.51
239.27
10 years
24.51
Extreme 24.51
239.27
More quotes
Managers TitleAgeSince
Founder 43 07-10-17
Founder 42 07-10-17
Founder 43 07-10-17
Members of the board TitleAgeSince
Director/Board Member 60 23-03-29
Founder 42 07-10-17
Founder 42 07-10-17
More insiders
Date Price Change Volume
24-05-07 29.92 -2.03% 1 487 137
24-05-07 30.54 +0.49% 1,297,090
24-05-06 30.39 +5.48% 1,674,251
24-04-30 28.81 -4.25% 2,182,192

End-of-day quote Shanghai S.E., May 07, 2024

More quotes
Shanghai Titan Scientific Co Ltd is a China-based company principally engaged in the research and development, production and sales of scientific research reagents, specialty chemicals, scientific research instruments and consumables, as well as providing laboratory construction and scientific research information services. The Company distributes its products through its own brands and third-party brands. The Company mainly distributes its products in domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
29.92 CNY
Average target price
36.87 CNY
Spread / Average Target
+23.22%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688133 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW